UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
University of California San Francisco
Give to UCSFRaising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Shinya Yamanaka's Nobel Prize for stem cell research brought fresh attention to something UCSF long ago sensed and seized: the promise of regeneration medicine for repairing or replacing damaged cells, tissues, and even whole organs.
UCSF recently convened experts to discuss cell therapies, which have already saved children and adults from leukemia in clinical trials after other drugs failed them.
UCSF scientists have discovered that muscle repair requires the action of two types of cells better known for causing inflammation and forming fat.
Specific DNA once dismissed as junk plays an important role in brain development and might be involved in several devastating neurological diseases, UCSF scientists have found.
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers who have outlined their vision of cell-based therapeutics as a “third pillar of medicine."
Scientists at UC San Francisco will host a one day symposium, “Cell-Based Therapeutics: The Next Generation of Medicine,” with some of the nation’s leading clinical and laboratory researchers in stem cell therapy, immunotherapy and bacterial therapeutics.
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages, UCSF researchers have discovered.